Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir.
Janoly-Duménil
A
A
Galambrun
C
C
Basset
T
T
Mialou
V
V
Bertrand
Y
Y
Bleyzac
N
N
D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D016903:Drug Monitoring / Q000379:methods; D018792:Encephalitis, Viral / Q000188:drug therapy* / Q000209:etiology; D015774:Ganciclovir / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015654:Herpesvirus 6, Human / Q000187:drug effects* / Q000472:pathogenicity; D006801:Humans; D016867:Immunocompromised Host; D007677:Kidney Function Tests; D008297:Male; D019349:Roseolovirus Infections / Q000150:complications / Q000188:drug therapy* / Q000209:etiology
D000998:Antiviral Agents; D015774:Ganciclovir